R&D
Pfizer partners with NIHR to boosts UK R&D
July 1, 2015Research and Development Manchester, NIHR, Pfizer, R&D, Sally Davies
Pfizer has signed an agreement with the National Institute for Health Research Clinical Research Network to conduct more clinical research …
BMS enters gene therapy development deal
April 7, 2015Research and Development BMS, Bristol-Myers Squibb, R&D, cardiovascular disease, cvd, heart disease, heart failure, uniQure
Bristol-Myers Squibb (BMS) has signed a multi-million dollar agreement with Amsterdam-based gene therapy firm uniQure to boost research into new …
Big pharma spent $112 billion on R&D in 2013
December 17, 2014Research and Development, Sales and Marketing Merck, Pfizer, R&D, Roche, data, global data, research
The top 30 pharma companies spent a combined total of $112 billion on research and development last year. Calculated to …
Teva to ditch R&D in cancer and women’s health
October 6, 2014Manufacturing and Production, Research and Development, Sales and Marketing Copaxone, FDA, MS, R&D, Teva, cuts, generics
Teva will stop research into oncology and women’s health in order to cut costs and focus more on generics and …
AstraZeneca rejects Pfizer’s ‘final offer’
May 19, 2014Medical Communications, Research and Development, Sales and Marketing AstraZeneca, MPs, Pfizer, R&D, UK, science, takeover
AstraZeneca has this morning rejected a new bid from Pfizer that could have seen the US giant pay £69 billion …
BIA welcomes budget statement
March 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Budget, Osborne, R&D, seed, sme
An increase in R&D tax credits and the creation of a cell therapy manufacturing centre were two of the highlights …
AstraZeneca sells Alderley Park
March 13, 2014Research and Development, Sales and Marketing AstraZeneca, Manchester, Osborne, R&D, alderley park, research
AstraZeneca has sold its former R&D site in Cheshire to a public-private consortium for an undisclosed sum, and expects the …
Forest cuts jobs in restructure
December 4, 2013Research and Development, Sales and Marketing Forest Labs, R&D, US, cuts
Forest Laboratories is restructuring and shedding jobs in a bid to save $500 million in costs by the end of …
Report: ‘R&D isn’t paying’
December 3, 2013Research and Development, Sales and Marketing Deloitte, R&D, pharma, research and development, reuters
On average, the world’s biggest pharma companies are not getting enough of a return out of their R&D efforts, according …
Eisai reorganises R&D
December 2, 2013Research and Development, Sales and Marketing Eisai, R&D, cfu, epcs, pcu, reorganisation
Tokyo-based Eisai is to axe 130 jobs in Europe and the US as part of an attempt to shake up …
Coalition launches rare disease strategy
November 22, 2013Research and Development, Sales and Marketing DoH, NHS, R&D, rare disease
The Department of Health has launched the UK’s first strategy on rare diseases as part of a bid to boost …
Merck axes 8,500 more jobs
October 2, 2013Medical Communications, Research and Development, Sales and Marketing Jobs, Merck, R&D, cuts
Amgen to open Chinese R&D centre
September 26, 2013Research and Development, Sales and Marketing Amgen, China, R&D, Zhejiang
Amgen has signalled its intention to expand in China by announcing the opening of an R&D centre which will focus …
Teva in Cancer Research UK tie-up
September 20, 2013Medical Communications, Research and Development, Sales and Marketing CRUK, Cancer, R&D, Teva
NICE queries pharma R&D costs
September 5, 2013Research and Development, Sales and Marketing Dillon, NICE, Pfizer, R&D
NICE has questioned whether pharma really spends as much as it says it does on bringing new treatments to market …
